demonstrated that Treg cells lacking GARP were unable to suppress pathogenic T cell responses, promoted inflammation, and improved anti-tumor immunity in the inflammation-associated colon cancer model (14). This evidence concerns the gene LRRC32 and colonic neoplasm.